Hyperliquid Strategies (NASDAQ:PURR) Price Target Raised to $35.00

Hyperliquid Strategies (NASDAQ:PURR) had its price objective raised by research analysts at Cantor Fitzgerald from $34.30 to $35.00 in a research report issued on Friday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Cantor Fitzgerald‘s target price would suggest a potential upside of 299.09% from the stock’s current price.

Other equities analysts also recently issued research reports about the stock. Chardan Capital raised their target price on shares of Hyperliquid Strategies from $9.75 to $17.00 and gave the company a “buy” rating in a research note on Friday, August 28th. Compass Point assumed coverage on Hyperliquid Strategies in a research report on Monday, September 14th. They issued a “buy” rating and a $18.00 price target on the stock. Wall Street Zen downgraded Hyperliquid Strategies from a “hold” rating to a “sell” rating in a research note on Sunday, October 11th. Finally, Weiss Ratings downgraded Hyperliquid Strategies from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 23rd. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $20.00.

Hyperliquid Strategies Price Performance

Shares of NASDAQ PURR opened at $8.77 on Friday. Hyperliquid Strategies has a 1 year low of $3.01 and a 1 year high of $14.76. The stock has a market cap of $2.44 billion, a P/E ratio of -1.37 and a beta of 1.92. The firm has a 50-day moving average of $11.30 and a 200 day moving average of $8.02.

Hyperliquid Strategies (NASDAQ:PURR) last posted its quarterly earnings data on Thursday, November 5th. The company reported $2.54 EPS for the quarter, topping the consensus estimate of $2.10 by $0.44. Research analysts expect that Hyperliquid Strategies will post 2.63 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Hyperliquid Strategies

Several large investors have recently modified their holdings of PURR. BlackRock Inc. bought a new position in Hyperliquid Strategies in the 2nd quarter worth about $79,842,000. Paradigm Operations LP bought a new position in Hyperliquid Strategies in the 2nd quarter worth about $44,936,535. OLP CAPITAL MANAGEMENT Ltd purchased a new stake in Hyperliquid Strategies during the 1st quarter valued at about $10,459,000. Galaxy Digital Inc. purchased a new stake in Hyperliquid Strategies during the 1st quarter valued at about $4,581,000. Finally, Wealth High Governance Capital Ltda purchased a new stake in Hyperliquid Strategies during the 2nd quarter valued at about $6,517,000. Hedge funds and other institutional investors own 9.45% of the company’s stock.

Trending Headlines about Hyperliquid Strategies

Here are the key news stories impacting Hyperliquid Strategies this week:

• Positive Sentiment: Q3 earnings were $2.54 per share, above the $2.10 analyst consensus. The company reported $620.6 million in net income and $13.3 million in revenue. Company financial results
• Positive Sentiment: The company applied to the CFTC to register as a futures commission merchant, aiming to support U.S.-based futures trading. If approved, the move could broaden its market access and business opportunities. CoinDesk article on the U.S. futures platform plan
• Neutral Sentiment: CEO David Schamis said the company deployed $802 million during the quarter and described that investment and the FCM application as linked strategic moves. Company financial results
• Negative Sentiment: Most of the $620.6 million profit came from unrealized gains in HYPE holdings, rather than recurring operating revenue. That makes reported earnings sensitive to token-price swings, while the FCM application still requires regulatory approval. Article on unrealized HYPE gains

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.